Stock Events

Stock Events

Search...

Ovid Therapeutics (OVID) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.22

-0.11

0.01

0.12

Details

Expected EPS

-0.137517

Actual EPS

-0.14

Surprise EPS

-0

Surprise Percent

+1.81%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.14 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.